Exposure to higher than normal levels of PTH can cause various hypercalcemia-related clinical manifestations, with an incidence of maternal complications of approximately 67% and that of fetal or neonatal complications of approximately 80%, leading to 30% fetal or neonatal deaths [2]. The gene discussed is PTH; the disease is hypercalcemia disease.